Therapy Management

Orchestrate every step of cell, gene & complex drug therapies on one audit‑ready platform

From referral to long‑term outcomes, Zelthy unifies scheduling, chain‑of‑identity, safety, and reimbursement so teams hit life‑saving timelines—not roadblocks.

The Enterprise Challenge

Disjointed tooling

Teams juggle CRMs, courier portals, LIMS, and spreadsheets, delaying onboarding by weeks.

Chain‑of‑identity

Risk grows with every manual hand‑off between apheresis sites, CMOs, and treatment centers.

Regulators demand proof

(21 CFR Part 11, EMA GMP Annex 13, GDPR) of every decision and timestamp.

What You Get

Option - Pre-built Apps

Best For - Rapid CAR‑T & gene‑therapy launches

What you get - SOP‑aligned templates, chain‑of‑identity tracker, REMS module

Option - Option - AI Agents

Best For - Automating critical coordination

What you get - Delay‑prediction bot, capacity‑balancing bot, automated deviation summarizer

Option - Custom Apps

Best For - Novel therapy models

What you get - Low‑code builder for bespoke workflows & data‑models

Security & Compliance

GxP & 21 CFR Part 11 validation
ISO 27001 & SOC 2 Type II certified
HIPAA & GDPR privacy controls
Regional data residency options (EU, US, APAC)

Zelthy Operating System for Therapies

AI Insights Layer

Predicts vein‑to‑vein delays and recommends rescheduling before conflicts occur.
Flags temperature‑excursion risk via courier telemetry.
Generates real‑world‑evidence dashboards trusted by medical affairs.